Search

Your search keyword '"Verma, Chandra S."' showing total 769 results

Search Constraints

Start Over You searched for: Author "Verma, Chandra S." Remove constraint Author: "Verma, Chandra S."
769 results on '"Verma, Chandra S."'

Search Results

1. PARP4 interacts with hnRNPM to regulate splicing during lung cancer progression

2. Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists

3. Domain-specific p53 mutants activate EGFR by distinct mechanisms exposing tissue-independent therapeutic vulnerabilities

7. Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

8. High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

10. List of contributors

22. Mechanisms of biased agonism by Gαi/o-biased stapled peptide agonists of the relaxin-3 receptor.

25. Molecular descriptors suggest stapling as a strategy for optimizing membrane permeability of cyclic peptides.

28. A high‐throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell‐based assays

29. Data from TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

30. Supplementary Figures from TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

31. Supplementary Tables from TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

32. Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation

33. A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma

37. Design-Rules for Stapled Alpha-Helical Peptides with On-Target In Vivo Activity: Application to Mdm2/X dual antagonists

49. Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology

50. Abstract 5239: Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation

Catalog

Books, media, physical & digital resources